Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bendazol (also known as dibazol) is a small molecule vasodilator primarily used in Russia and some other countries. It acts directly on vascular smooth muscle to dilate blood vessels and reduce peripheral resistance, thereby lowering blood pressure. Bendazol is indicated for the treatment of arterial hypertension, hypertensive crisis, spasms of internal organs (such as stomach ulcers and intestinal spasms), and certain nervous system diseases including residual effects of poliomyelitis. It can also enhance nitric oxide synthase activity in renal glomeruli and collecting tubules, contributing to its hypotensive effect[1][5][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bendazol.